Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 6:33 PM
Ignite Modification Date:
2025-12-24 @ 6:33 PM
NCT ID:
NCT00271557
Eligibility Criteria:
Inclusion Criteria:
* Patients with a previous history of chronic congestive heart failure (CHF)
* presenting with symptomatic, decompensated CHF for inpatient intravenous therapy with medications that influence the tone and caliber of blood vessels (other than, or in addition to, diuretics)
Exclusion Criteria:
* Patients with myocardial ischemia within the past 48 hours
* having significant valvular stenosis, obstructive cardiomyopathy, constrictive pericarditis or primary pulmonary hypertension
* being treated with intravenous (IV) therapy with medications that influence the tone and caliber of blood vessels for \> 4 hours for this episode of CHF
* already being treated with IV therapy with medications that influence the tone and caliber of blood vessels that cannot be discontinued
* having cardiogenic shock, systolic blood pressure consistently \< 90 mm Hg or other significant blood circulation instability.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00271557
Study Brief:
Protocol Section:
NCT00271557